Morgan Stanley Expansion Capital Invests $24M in ValGenesis

May 4, 2021

Morgan Stanley Expansion Capital has made a $24 million growth investment in ValGenesis, a provider of cloud-based validation lifecycle management (VLMS) software for the life sciences. Proceeds will bolster sales, accelerate product innovation in digital validation technologies, and support global deployment.

Targets
ValGenesis
Industry
Cloud & SaaS
Location
California, United States
Transaction Type
Growth capital

Explore More

Related Acquisitions

Build a buyer list for your deal

Find active buyers from recent acquisition patterns and move straight into outreach.